This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Promethera raises €39.7mm through Series D round; closes round at €47.2mm
Promethera Biosciences SA NV raised €39.7mm ($44.4mm) through its Series D round. Itochu Corp. co-led the round with a €10mm investment, along with Shinsei Capital Partners, and the pair were joined by additional buyers Medipal Holdings, Mirae Asset Capital, the family office Six Snow, Korea Investment Partners, Ci:z Investment LLP, Mitsui & Co., and Belgian private investors. Proceeds will support Promethera's HepaStem cell technology platform (liver-derived stem cells from healthy donated organs and expanded in a lab) for acute-on-chronic liver failure (ACLF) and initiation of a clinical trial in NASH.
Drug Discovery Tools
Gene Therapy, Cell Therapy
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?